STTCOMP 1AD, FA Long - Bio
(ASX: 1AD – AdAlta Limited)
SP: 22c
MC: $22 Million
Cash $10M (AUD)
Shares: 100M, with over 50M in escrow for 6-24 months. 70% owned by cornerstone investors, including Platinum Asset Management (8%).
AdAlta has an advanced lead fibrosis drug candidate AD-114 with significant pre-clinical validation. Recently listed to accelerate the development of its drug, which has numerous advantages over the existing treatments. Big global market of more than 4.2b.
An investor presentation was released today, which strongly suggests the end game is to be snapped up by big pharma. The company will be presenting to brokers next week, which may prove a price catalyst. Thus far it has been quite illiquid, and there is not ONE post on the HC forum!! I know bio is not so much in favour at the moment, but the presentation is well-worth a read IMO and this could be one diamond in the rough.
First ever tip, go easy on me!
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 5th Sept
Short Term Trading Week Starting: 5th Sept, page-448
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online